Gender differences in depression and response to psychotropic medication

Weissman, 1996, Cross-national epidemiology of major depression and bipolar disorder, JAMA, 276, 293, 10.1001/jama.1996.03540040037030

Kessler, 1993, Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence, J Affect Disord., 29, 85, 10.1016/0165-0327(93)90026-G

Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002

Coryell, 1982, Excess mortality in panic disorder. A comparison with primary unipolar depression, Arch Gen Psychiatry, 39, 701, 10.1001/archpsyc.1982.04290060051010

Depression Guideline Panel, 1993

Hirschfeld, 1997, Assessment and treatment of suicidal patients, N Engl J Med., 337, 910, 10.1056/NEJM199709253371307

Takeshita, 2002, Are depressive symptoms a risk factor for mortality in elderly Japanese American men? The Honolulu-Asia Aging Study, Am J Psychiatry, 159, 1127, 10.1176/appi.ajp.159.7.1127

Ferketich, 2000, Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey, Arch Intern Med., 160, 1261, 10.1001/archinte.160.9.1261

Penninx, 2001, Depression and cardiac mortality: Results from a community-based longitudinal study, Arch Gen Psychiatry, 58, 221, 10.1001/archpsyc.58.3.221

Krishnan, 2000, Depression as a contributing factor in cerebrovascular disease, Am Heart J, 140, 70, 10.1067/mhj.2000.109980

Cizza, 2001, Depression: A major, unrecognized risk factor for osteoporosis?, Trends Endocrinol Metab., 12, 198, 10.1016/S1043-2760(01)00407-6

Michelson, 1996, Bone mineral density in women with depression, N Engl J Med., 335, 1176, 10.1056/NEJM199610173351602

Robbins, 2001, The association of bone mineral density and depression in an older population, J Am Geriatr Soc., 49, 732, 10.1046/j.1532-5415.2001.49149.x

Lustman, 2000, Depression and poor glycemic control: A metaanalytic review of the literature, Diabetes Care, 23, 934, 10.2337/diacare.23.7.934

Mazze, 1984, Psychological and social correlates of glycemic control, Diabetes Care, 7, 360, 10.2337/diacare.7.4.360

Testa, 1998, Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial, JAMA, 280, 1490, 10.1001/jama.280.17.1490

Lustman, 1998, Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial, Ann Intern Med., 129, 613, 10.7326/0003-4819-129-8-199810150-00005

Lustman, 1997, Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial, Psychosom Med., 59, 241, 10.1097/00006842-199705000-00007

Lustman, 2000, Fluoxetine for depression in diabetes: A randomized double-blind placebo-controlled trial, Diabetes Care, 23, 618, 10.2337/diacare.23.5.618

Williams, 2004, The effectiveness of depression care management on diabetes-related out comes in older patients, Ann Intern Med., 140, 1015, 10.7326/0003-4819-140-12-200406150-00012

Katon, 2004, The Pathways Study: A randomized trial of collaborative care in patients with diabetes and depression, Arch Gen Psychiatry, 61, 1042, 10.1001/archpsyc.61.10.1042

Brown, 2004, Association of depression with medical illness: Does cortisol play a role?, Biol Psychiatry, 55, 1, 10.1016/S0006-3223(03)00473-6

2000

Brent, 2002, Clinical practice. Adolescent depression, N Engl J Med., 347, 667, 10.1056/NEJMcp012249

Harris, 2004, The impact of age, gender, race, and ethnicity on the diagnosis and treatment of depression, J Manag Care Pharm., 10, S2

Aragones, 2005, Somatized depression in primary care attenders, J Psychosom Res., 58, 145, 10.1016/j.jpsychores.2004.07.010

Rapaport, 1995, Gender differences in outpatient research subjects with affective disorders: A comparison of descriptive variables, J Clin Psychiatry, 56, 67

Leibenluft, 1995, Gender differences in seasonal affective disorder, Depression, 3, 13, 10.1002/depr.3050030104

Somerset Pharmaceuticals Inc., 2005

Amsterdam, 2003, A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder, J Clin Psychiatry, 64, 208, 10.4088/JCP.v64n0216

Spina, 2002, Clinically significant drug interactions with antidepressants in the elderly, Drugs Aging, 19, 299, 10.2165/00002512-200219040-00004

Stahl, 2000

2000

US Food and Drug Administration, 2004

Weiss, 2005, Antidepressant adherence and suicide risk in depressed youth, Am J Psychiatry, 162, 1756, 10.1176/appi.ajp.162.9.1756-a

Jick, 2004, Antidepressants and the risk of suicidal behaviors, JAMA, 292, 338, 10.1001/jama.292.3.338

Martinez, 2005, Antidepressant treatment and the risk of fatal and nonfatal self harm in first episode depression: Nested case-control study, BMJ, 330, 389, 10.1136/bmj.330.7488.389

Gibbons, 2005, The relationship between antidepressant medication use and rate of suicide, Arch Gen Psychiatry, 62, 165, 10.1001/archpsyc.62.2.165

Grunebaum, 2004, Antidepressants and suicide risk in the United States, 1985–1999, J Clin Psychiatry, 65, 1456, 10.4088/JCP.v65n1103

Olfson, 2003, Relationship between antidepressant medication treatment and suicide in adolescents, Arch Gen Psychiatry, 60, 978, 10.1001/archpsyc.60.9.978

Hamilton, 1996, Sex and treatment of depression: When does it matter?, 241

Kornstein, 2000, Gender differences in treatment response to sertraline versus imipramine in chronic depression, Am J Psychiatry, 157, 1445, 10.1176/appi.ajp.157.9.1445

Entsuah, 2001, Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo, J Clin Psychiatry, 62, 869, 10.4088/JCP.v62n1106

Quitkin, 2002, Are there differences between women's and men's antidepressant responses?, Am J Psychiatry, 159, 1848, 10.1176/appi.ajp.159.11.1848

Hildebrandt, 2003, Are gender differences important for the clinical effects of antidepressants?, Am J Psychiatry, 160, 1643, 10.1176/appi.ajp.160.9.1643

Wohlfarth, 2004, Response to tricyclic antidepressants: Independent of gender?, Am J Psychiatry, 161, 370, 10.1176/appi.ajp.161.2.370

Freeman, 2003, Premenstrual dysphoric disorder: Recognition and treatment, Prim Care Companion J Clin Psychiatry, 5, 30, 10.4088/PCC.v05n0106

Spinelli, 2003, Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women, Am J Psychiatry, 160, 555, 10.1176/appi.ajp.160.3.555

Wisner, 1999, Pharmacologic treatment of depression during pregnancy, JAMA, 282, 1264, 10.1001/jama.282.13.1264

Simon, 2002, Outcomes of prenatal antidepressant exposure, Am J Psychiatry, 159, 2055, 10.1176/appi.ajp.159.12.2055

Nulman, 2002, Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study, Am J Psychiatry, 159, 1889, 10.1176/appi.ajp.159.11.1889

Gentile, 2005, The safety of newer antidepressants in pregnancy and breastfeeding, Drug Saf., 28, 137, 10.2165/00002018-200528020-00005

Hallberg, 2005, The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: A review and clinical aspects, J Clin Psychopharmacol, 25, 59, 10.1097/01.jcp.0000150228.61501.e4

Sanz, 2005, Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis, Lancet, 365, 482, 10.1016/S0140-6736(05)17865-9

US Food and Drug Administration, Center for Drug Evaluation and Research, 2005

Hines, 2004, NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine, Birth Defects Res B Dev Reprod Toxicol, 71, 193, 10.1002/bdrb.20014

Moses-Kolko, 2005, Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications, JAMA, 293, 2372, 10.1001/jama.293.19.2372

Einarson, 2001, Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study, Am J Psychiatry, 158, 1728, 10.1176/appi.ajp.158.10.1728

Einarson, 2003, A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy, Can J Psychiatry, 48, 106, 10.1177/070674370304800207

Yaris, 2004, Newer antidepressants in pregnancy: Prospective outcome of a case series, Reprod Toxicol, 19, 235, 10.1016/j.reprotox.2004.07.004

Chun-Fai-Chan, 2005, Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study, Am J Obstet Gynecol, 192, 932, 10.1016/j.ajog.2004.09.027

Ansorge, 2004, Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice, Science, 306, 879, 10.1126/science.1101678

Heikkine, 2002, Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta, BJOG, 109, 1003, 10.1111/j.1471-0528.2002.01467.x

Hendrick, 2003, Placental passage of antidepressant medications, Am J Psychiatry, 160, 993, 10.1176/appi.ajp.160.5.993

Misri, 2002, Benefits and risks to mother and infant of drug treatment for postnatal depression, Drug Saf., 25, 903, 10.2165/00002018-200225130-00002

Misri, 2000, Are SSRIs safe for pregnant and breastfeeding women?, Can Fam Physician, 46, 626

Misri, 2000, Are SSRIs safe for pregnant and breastfeeding women?, Can Fam Physician, 46, 631

O'Hara, 2000, Efficacy of interpersonal psychotherapy for postpartum depression, Arch Gen Psychiatry, 57, 1039, 10.1001/archpsyc.57.11.1039

Yoshida, 1997, Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk, J Affect Disord, 43, 225, 10.1016/S0165-0327(97)01433-X

Whitby, 2005, The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding, Pharmacotherapy, 25, 411, 10.1592/phco.25.3.411.61597

Wisner, 2004, Prevention of postpartum depression: A pilot randomized clinical trial, Am J Psychiatry, 161, 1290, 10.1176/appi.ajp.161.7.1290

Fergusson, 1996, Childhood sexual abuse and psychiatric disorder in young adulthood: I. Prevalence of sexual abuse and factors associated with sexual abuse, J Am Acad Child Adolesc Psychiatry, 35, 1355, 10.1097/00004583-199610000-00023

Saewyc, 2003, The prevalence of sexual abuse among adolescents in school, J Sch Nurs., 19, 266, 10.1177/10598405030190050401

Bifulco, 1991, Early sexual abuse and clinical depression in adult life, Br J Psychiatry, 159, 115, 10.1192/bjp.159.1.115

Mullen, 1993, Childhood sexual abuse and mental health in adult life, Br J Psychiatry, 163, 721, 10.1192/bjp.163.6.721

Fergusson, 1996, Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse, J Am Acad Child Adolesc Psychiatry, 35, 1365, 10.1097/00004583-199610000-00024

Weiss, 1999, Childhood sexual abuse as a risk factor for depression in women: Psychosocial and neurobiological correlates, Am J Psychiatry, 156, 816, 10.1176/ajp.156.6.816

Peleikis, 2004, The relative influence of childhood sexual abuse and other family background risk factors on adult adversi ties in female outpatients treated for anxiety disorders and depression, Child Abuse Negl., 28, 61, 10.1016/j.chiabu.2003.08.003

Stein, 1996, Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample, Am J Psychiatry, 153, 275, 10.1176/ajp.153.2.275

Safren, 2002, History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder, J Nerv Ment Dis., 190, 453, 10.1097/00005053-200207000-00005

Davidson, 1991, Posttraumatic stress disorder in the community: An epidemiological study, Psychol Med., 21, 713, 10.1017/S0033291700022352

De Bellis, 2003, Biologic findings of post-traumatic stress disorder and child maltreatment, Curr Psychiatry Rep., 5, 108, 10.1007/s11920-003-0027-z

Liu, 2000, Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinepherine release in the hypothalamic paraventricular nucleus, J Neuroendocrinol, 12, 5, 10.1046/j.1365-2826.2000.00422.x

Ladd, 2004, Longterm adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation, Biol Psychiatry, 55, 367, 10.1016/j.biopsych.2003.10.007

Sheline, 1996, Hippocampal atrophy in major depression: A result of depression-induced neurotoxicity?, Mol Psychiatry, 1, 298

Reagan, 1997, Controversies surrounding glucocorticoid-mediated cell death in the hippocampus, J Chem Neuroanat, 13, 149, 10.1016/S0891-0618(97)00031-8

Belanoff, 2001, Rapid reversal of psychotic depression using mifepristone, J Clin Psychopharmacol, 21, 516, 10.1097/00004714-200110000-00009

Fischer, 2005, Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion, N Engl J Med., 353, 2352, 10.1056/NEJMoa051620

Wallace, 1995, Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients, Am J Psychiatry, 152, 929, 10.1176/ajp.152.6.929

Jansen, 2001, Toward individualized evidencebased medicine: Five “N of 1” trials of methyl phenidate in geriatric patients, J Am Geriatr Soc., 49, 474, 10.1046/j.1532-5415.2001.49092.x

Lazarus, 1992, Efficacy and side effects of methylphenidate for poststroke depression, J Clin Psychiatry, 53, 447

Grade, 1998, Methylphenidate in early poststroke recovery: A doubleblind, placebo-controlled study, Arch Phys Med Rehabil, 79, 1047, 10.1016/S0003-9993(98)90169-1

White, 1992, Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: An n-of-1 trial, J Clin Psychiatry, 53, 153

Fernandez, 1995, Effects of methylphenidate in HIV-related depression: A comparative trial with desipramine, Int J Psychiatry Med., 25, 53, 10.2190/16FH-9ECT-Y280-VV45

Macleod, 1998, Methylphenidate in terminal depression, J Pain Symptom Manage, 16, 193

Homsi, 2000, Methylphenidate for depression in hospice practice: A case series, Am J Hosp Palliat Care, 17, 393, 10.1177/104990910001700610

Homsi, 2001, A phase II study of methylphenidate for depression in advanced cancer, Am J Hosp Palliat Care, 18, 403, 10.1177/104990910101800610

Rozans, 2002, Palliative uses of methylphenidate in patients with cancer: A review, J Clin Oncol., 20, 335, 10.1200/JCO.20.1.335

Rothenhausler, 2000, Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit, J Clin Psychiatry, 61, 750, 10.4088/JCP.v61n1007

Lavretsky, 2001, Methylphenidate augmentation of citalopram in elderly depressed patients, Am J Geriatr Psychiatry, 9, 298, 10.1097/00019442-200108000-00015

Lavretsky, 2003, Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: An open trial, J Clin Psychiatry, 64, 1410, 10.4088/JCP.v64n1202

Morgan, 2005, Estrogen augmentation of antidepressants in perimenopausal depression: A pilot study, J Clin Psychiatry, 66, 774, 10.4088/JCP.v66n0617

Soares, 2003, Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimeno pausal and postmenopausal women with depression and vasomotor symptoms, J Clin Psychiatry, 64, 473, 10.4088/JCP.v64n0419

Schneider, 1997, Estrogen replacement and response to fluoxe tine in a multicenter geriatric depression trial, Am J Geriatr Psychiatry, 5, 97, 10.1097/00019442-199700520-00002

Rasgon, 2002, Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women, J Clin Psychiatry, 63, 45

Liu, 2004, Menopausal depression: Comparison of hormone replacement therapy and hormone replacement therapy plus Fuoxetine, Chin Med J (Engl), 117, 189

Schneider, 2001, Estrogen replacement therapy and antidepressant response to sertraline in older depressed women, Am J Geriatr Psychiatry, 9, 393, 10.1176/appi.ajgp.9.4.393

Tanapat, 1999, Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat, J Neurosci., 19, 5792, 10.1523/JNEUROSCI.19-14-05792.1999

McEwen, 1982, Gonadal steroid action on the brain: Neurochemistry and neuropharmacology, Annu Rev Pharmacol Toxicol., 22, 555, 10.1146/annurev.pa.22.040182.003011

Woolley, 1998, Hormonal effects on the brain, Epilepsia, 39, S2, 10.1111/j.1528-1157.1998.tb02601.x